Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Targeting IL-17 could help treat pattern hair loss.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.

Notch1 helps skin heal by attracting specific immune cells.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Laminin-511 is essential for proper melanocyte movement and development in mice.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Higher IL-21 levels may help predict alopecia areata activity.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

The Itpr3 gene causes a specific hair pattern in mice.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.